Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)
Authors:
- Hai-Bin WangHWHai-Bin Wang
- Jun LaiJLJun Lai
- Ying-Chun XuYXYing-Chun Xu
- Chen ZhangCZChen Zhang
- Shu-Qing ChenSCShu-Qing Chen
- 1 December 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (36) , 9115-9123
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Department of Zhejiang Province (2009C13034)
This publication has 25 references indexed in Scilit:
- Novel Conjugation of Tumor‐Necrosis‐Factor‐Related Apoptosis‐Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug DeliveryAdvanced Materials, 2013
- Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAILInvestigational New Drugs, 2010
- Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing LigandMolecular Cancer Therapeutics, 2010
- Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasThe Journal of Pathology, 2003
- Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAILJournal of Biological Chemistry, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminaseThe Journal of Pediatrics, 1988